Pharmanext SRL
3.6 FTEThe score of Pharmanext shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +109 % Total assets +102 % Headcount (avg FTE) +3 %
Accounts of the company itself (not consolidated).
The full file covers 7 financial years; a free account shows 2. →Pharmanext's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 26 Jun 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 22 Oct 2024
- Year ended 31 Dec 2022filed on 01 Aug 2023
- Year ended 31 Dec 2021filed on 13 Oct 2022
Pharmanext's financial analysis
- Solvency22.8%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharmanext
Pharmanext's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0705.998.068
- VAT number
- BE0705998068
- Peppol
- Registered · 0208:0705998068 · as of 26 Oct 2026
- Legal form
- SRL
- Incorporated
- 28 Sep 2018
- Registered office
- 1050 Ixelles
- Size
- Micro · 3.6 FTE
- Latest accounts
- 2025 · filed on 26 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Pharmanext (SRL) has been based in Ixelles since 2018, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 169,596 € and equity of 531,183 €; its revenue is not published. With 3.6 full-time equivalents, it is a micro-enterprise by headcount. Its solvency stands at 22.8%, below the median of its sector (37.8%).
Companies similar to Pharmanext
Companies in the same business, of comparable size and area, outside its group.
- PG Pharmaceuticals Business and other management consultancy activities Opwijk · balance sheet €1.86m
- Pharmacie Brasseur L. Business and other management consultancy activities Wavre · balance sheet €1.05m
- Degrofarm Retail sale of pharmaceutical products Deinze · balance sheet €1.47m
- APO2370 Retail sale of pharmaceutical products Arendonk · balance sheet €3.86m
- Pavobur Retail sale of pharmaceutical products Vosselaar · balance sheet 943,141 €
- Alphar Leglise Retail sale of pharmaceutical products Léglise · balance sheet €2.53m
- LA Roche Pharma Retail sale of pharmaceutical products La Roche-en-Ardenne · balance sheet €1.97m
- Omnicare Farma Dam Retail sale of pharmaceutical products Lokeren · balance sheet €1.25m
Frequently asked questions about Pharmanext
What is the revenue of Pharmanext?
Pharmanext files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharmanext?
In Belgium, the VAT number is the company number prefixed with BE: BE0705998068 for Pharmanext, if the company is VAT-registered. Its company number (CBE) is 0705.998.068.
Where is the registered office of Pharmanext?
According to the CBE register, the registered office of Pharmanext is in 1050 Ixelles.
What is the equity of Pharmanext?
At the close of the 2025 financial year, the equity of Pharmanext amounts to 531,183 €, a solvency of 22.8% of total assets.
How many people work at Pharmanext?
3.6 full-time equivalents on average according to the 2025 social balance sheet.
Who manages Pharmanext?
The register lists 2 active mandates at Pharmanext. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharmanext
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →